Curis PE Ratio 2006-2021 | CRIS

Current and historical p/e ratio for Curis (CRIS) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Curis PE ratio as of October 26, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Curis PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-10-27 6.66 0.00
2021-06-30 8.07 $-0.45 0.00
2021-03-31 11.32 $-0.50 0.00
2020-12-31 8.19 $-0.67 0.00
2020-09-30 1.17 $-0.82 0.00
2020-06-30 1.21 $-0.90 0.00
2020-03-31 0.70 $-0.95 0.00
2019-12-31 1.70 $-0.97 0.00
2019-09-30 2.24 $-0.89 0.00
2019-06-30 1.86 $-0.92 0.00
2019-03-31 1.99 $-0.96 0.00
2018-12-31 0.69 $-1.01 0.00
2018-09-30 1.78 $-1.08 0.00
2018-06-30 1.73 $-1.41 0.00
2018-03-31 3.27 $-1.65 0.00
2017-12-31 3.50 $-1.85 0.00
2017-09-30 7.45 $-2.00 0.00
2017-06-30 9.45 $-2.50 0.00
2017-03-31 13.90 $-2.45 0.00
2016-12-31 15.40 $-2.25 0.00
2016-09-30 13.05 $-2.35 0.00
2016-06-30 7.80 $-1.50 0.00
2016-03-31 8.05 $-1.35 0.00
2015-12-31 14.55 $-2.50 0.00
2015-09-30 10.10 $-2.35 0.00
2015-06-30 16.55 $-2.45 0.00
2015-03-31 12.00 $-2.25 0.00
2014-12-31 7.50 $-1.05 0.00
2014-09-30 7.05 $-0.95 0.00
2014-06-30 9.30 $-0.75 0.00
2014-03-31 14.10 $-0.75 0.00
2013-12-31 14.10 $-0.75 0.00
2013-09-30 22.30 $-1.25 0.00
2013-06-30 15.95 $-1.35 0.00
2013-03-31 16.40 $-1.45 0.00
2012-12-31 17.15 $-1.00 0.00
2012-09-30 20.70 $0.10 207.00
2012-06-30 27.00 $0.05 540.00
2012-03-31 24.10 $-0.05 0.00
2011-12-31 23.40 $-0.65 0.00
2011-09-30 15.80 $-1.35 0.00
2011-06-30 17.90 $-1.20 0.00
2011-03-31 16.25 $-1.05 0.00
2010-12-31 9.90 $-0.30 0.00
2010-09-30 6.85 $-0.15 0.00
2010-06-30 6.95 $-0.35 0.00
2010-03-31 15.35 $-0.55 0.00
2009-12-31 16.25 $-0.75 0.00
2009-09-30 11.70 $-0.70 0.00
2009-06-30 8.00 $-0.75 0.00
2009-03-31 6.90 $-0.55 0.00
2008-12-31 3.75 $-0.90 0.00
2008-09-30 5.75 $-0.40 0.00
2008-06-30 7.30 $-0.35 0.00
2008-03-31 7.10 $-0.60 0.00
2007-12-31 4.90 $-0.70 0.00
2007-09-30 4.90 $-1.00 0.00
2007-06-30 5.85 $-0.85 0.00
2007-03-31 7.60 $-0.85 0.00
2006-12-31 6.30 $-0.90 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.624B $0.011B
Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86